When Is Osteonecrosis Not Osteonecrosis?: Adjudication of Reported Serious Adverse Joint Events in the Tanezumab Clinical Development Program
暂无分享,去创建一个
E. Vignon | D. Hungerford | M. Hochberg | S. Abramson | C. West | K. Verburg | Michael D. Smith | L. Tive